degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatas audzēji - citi hormonu antagonisti un tiem līdzīgas vielas - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
prescanden hct 32 mg/12,5 mg tabletes
sandoz d.d., slovenia - candesartanum cilexetilum, hydrochlorothiazidum - tabletes - 32 mg/12,5 mg
prescanden hct 32 mg/25 mg tabletes
sandoz d.d., slovenia - candesartanum cilexetilum, hydrochlorothiazidum - tabletes - 32 mg/25 mg
prescanden hct 8 mg/12,5 mg tabletes
sandoz d.d., slovenia - candesartanum cilexetilum, hydrochlorothiazidum - tabletes - 8 mg/12,5 mg
prescanden hct 16 mg/12,5 mg tabletes
sandoz d.d., slovenia - candesartanum cilexetilum, hydrochlorothiazidum - tabletes - 16 mg/12,5 mg
temozolomide accord
accord healthcare s.l.u. - temozolomide - glioma; glioblastoma - antineoplastiski līdzekļi - pieaugušiem pacientiem ar nesen diagnosticētu multiformo glioblastomu vienlaikus ar staru terapiju (rt) un vēlāk kā monoterapijas terapiju. par attieksmi pret bērniem vecumā no trīs gadiem, pusaudžiem un pieaugušiem pacientiem ar ļaundabīgiem glioma, piemēram, glioblastoma multiforme vai anaplastic astrocytoma, parādot atkārtošanās vai progresēšanu pēc tam, kad standarta terapija.
canocord 4 mg tabletes
krka, d.d., novo mesto, slovenia - kandesartāna cileksetils - tablete - 4 mg
canocord 8 mg tabletes
krka, d.d., novo mesto, slovenia - kandesartāna cileksetils - tablete - 8 mg
canocord 16 mg tabletes
krka, d.d., novo mesto, slovenia - kandesartāna cileksetils - tablete - 16 mg
canocord 32 mg tabletes
krka, d.d., novo mesto, slovenia - kandesartāna cileksetils - tablete - 32 mg